Aarkstore - Complete 2015-16 Global Cord Blood Banking Industry Report
Summary
The global cord blood banking industry has matured substantially over the past few years, creating both serious threats and novel opportunities. Serious threats to the industry include:
New accreditation requirements that have increased the cost structure of cord blood banks
A decline in cord blood transplants in 2013, within the U.S. and other geographical regions
Low rates of turnover for stored cord blood units
Expensive cord blood transplantation procedures, costing from $200-300K each
Difficulty with educating obstetricians about cellular therapies
Poor press coverage in many regions worldwide, including major news outlets
Other uncontrollable factors that could threaten the industry include: new legislation, changes in transplant reimbursement, continually evolving accreditation requirements, the potential for competitive approaches to be shown as more optimal, patent challenges for processing or transplant technologies, changes in public perception of private vs. public banking, shift in policy recommendations by influential medical organizations, and changes in government support.
Marketing pressures are also impacting the industry, with the term “cord blood” becoming one of the 20 most expensive search terms on Google, reaching more than $20 per click for global search traffic and close to $40 per click for U.S. search traffic.
However, there are also emerging opportunities, including:
The potential to expand market size through increasing public awareness
New clinical trial data supporting applications for hematopoietic stem cells (HSCs) from cord blood and mesenchymal stem cells (MSCs) from cord tissue
Improving public perception toward stem cell therapies
Substantial deal-making within the industry, including...